Enzymatic Modifications of Protein S: Implications for Diagnostics and Anticoagulant Function
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Enzymatic modifications of protein S: cause and impact on diagnostics, plasma processing, and anticoagulant properties
This review discusses how enzymatic modifications, such as phosphorylation and proteolysis, can alter the anticoagulant functions of protein S, which is essential for downregulating coagulation.
These changes can impact diagnostic procedures, plasma product quality, and overall thrombosis risk, highlighting new opportunities for improved therapies and clinical diagnostics.
Read this paper.
Authors: Herm Jan Brinkman”
Article: Enzymatic modifications of protein S: cause and impact on diagnostics, plasma processing, and anticoagulant properties
Authors: Herm Jan Brinkman
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
-
Jun 3, 2026, 16:07Suraj Wilson: Back From ASCO 2026 With A Renewed Commitment To Cancer Research
-
Jun 3, 2026, 16:06Kerin A. Da Cruz: MSTU Team Is Creating The Future of Stroke Care In the Northeast Florida
-
Jun 3, 2026, 16:06Andrew Lee: Examining Rare Clotting Disorders After Adenovirus-Based COVID-19 Vaccination